Shenzhen Renhe Capital Management Co., Ltd. is a private equity firm based in Beijing, China, focusing on growth and mature stage investments. The firm targets a diverse range of sectors, including economic and industrial restructuring, urbanization, consumption upgrades, healthcare, technology media, clean technology, advanced manufacturing, cultural and leisure, and consumer goods. Renhe Capital also manages funds such as the Renhe RMB Fund VI, which specifically invests in healthcare, advanced manufacturing, education, and entertainment industries. Through its strategic investments, the firm aims to capitalize on emerging trends and drive value across its portfolio.
Kunhua Technology specializes in the development of fuel cell technology and product application. It collaborates with domestic photovoltaic and energy storage companies to build an integrated wind, light, storage, and hydrogen solution, as well as to jointly expand the hydrogen energy storage market.
UWLaser
Post in 2022
UWLaser is a provider of manufacturing solutions and precision laser welding equipment, specializing in complete sets of laser welding equipment and precision laser welding machines. It is a business that combines R&D, manufacturing, and sales.
Zezheng Pharmaceutical
Series B in 2021
Zezheng Bio is a pharmaceutical R&D firm that provides a drug delivery system for improved children's and generic drugs.
Zhengzheng Medicine
Series B in 2021
Zhengzheng Medicine is a pharmaceutical R&D enterprise focusing on high-end improved preparations. Founded in 2016, Zezheng Pharmaceutical is committed to taking the "ALZA" in the United States as an example, becoming a global drug delivery system (DrugDeliverySystem) research and development leader, determined to empower human health through medical technology innovation. Zezheng Medicine has established laboratories of 1,800 square meters and 8,200 square meters in Zibo, Shandong and Jiading, Shanghai respectively (including pilot workshops, high-end preparation laboratories, and high-active drug laboratories), and has deployed clinical operations and registration teams in many places around the world.
Huaxian Pharmaceutical
Series B in 2021
Huaxian Pharmaceutical is a biotechnology company. They produce highly sophisticated pharmaceutical goods for domestic and international pharmaceutical firms. They create raw materials and intermediates with a high degree of difficulty in the areas of anti-tumor, anti-virus, and anti-respiratory disorders.
Anrei Medical
Private Equity Round in 2021
Anrei Medical, established in 2006 and based in Hangzhou, China, is a wholly owned and FDA registered enterprise specializing in the development and manufacturing of disposable medical devices for minimally invasive procedures. The company focuses on devices used in various digestive surgeries, including gastroscopy and endoscopic retrograde cholangiopancreatography (ERCP). Anrei Medical is vertically integrated, overseeing all aspects of its operations from research and development to distribution and customer service, ensuring a comprehensive approach to meeting the needs of the healthcare market. Its established sales network allows it to effectively reach a wide range of customers, positioning the company as a key player in the medical device industry.
Cospowers
Series A in 2020
Cospowers is a technology-driven company that specializes in developing and manufacturing smart lithium battery solutions for a global clientele. Established in 2003, the company focuses on providing a one-stop comprehensive energy storage solution, which includes rechargeable batteries, chargers, and power battery packs. Cospowers employs advanced technology and scientific management methods to ensure product safety and reliability. Their offerings cater to various applications, including network energy, electric energy storage, and consumer batteries, promoting clean and efficient energy solutions. The products are well-received by customers, reflecting the company's commitment to quality and innovation in the energy storage sector.
Thoth Medical
Series B in 2020
Thoth Medical specializes in the development of medical wearables that incorporate advanced biomedical sensor technology. The company focuses on integrating various technologies, including wireless transmission, artificial intelligence algorithms, and cloud monitoring, to create devices that enhance clinical medical services. Thoth Medical aims to deliver precise, efficient, comfortable, and safe solutions for healthcare, ultimately improving patient care through innovative wearable technology.
Kangso Medical Laboratory
Series A in 2018
Kangso Medical Inspection is a prominent third-party testing institution in China, specializing in molecular genetic testing. It has established itself as a leading brand in the sector, having received clinical test qualifications in cellular molecular genetics. The organization emphasizes high efficiency, rigor, communication, and innovation in its operations. With over 2,300 square meters of laboratory space, Kangso is equipped with advanced inspection technology and supported by a skilled technical team, ensuring a robust management system. The company is dedicated to the research and development of molecular medicine, offering disease genetic testing solutions that enhance the accuracy of medical detection and support informed decision-making for its clients.
Hainan Wensheng New Material Technology
Venture Round in 2018
Hainan Wensheng New Material Technology is a manufacturer and supplier based in Haikou, China, specializing in the import, production, and distribution of metal ores, particularly zircon, ilmenite, and rutile. The company has established itself as one of the leading suppliers of zircon sand, titanium concentrate, and natural rutile within the Chinese market. Its strategic location in Haikou, the provincial capital of Hainan International Tourism Island, supports its operations and distribution efforts, enabling it to effectively meet the demands of various industries reliant on these materials.
Orbbec
Series D in 2018
Orbbec is a company that specializes in the design, research and development, production, and sales of 3D visual perception products. Founded by a team of experts in 3D vision and artificial intelligence, Orbbec focuses on creating advanced 3D motion sensors that enable computers to understand their environment in three dimensions. The company aims to make high-quality 3D cameras affordable and widely accessible, as it believes that these technologies will become essential for the future of intelligent computing. Orbbec's vision anticipates a time when the integration of 3D cameras in computing will be ubiquitous, transforming how machines interact with the world.
Beijing ACCB Biotech
Series C in 2017
Beijing ACCB Biotech Ltd. specializes in the research and development of cancer detection methods utilizing molecular biology technologies. The company offers a range of services centered on personalized therapy, including early cancer screening, drug selection, effect tracking, prognostic evaluation, and monitoring for transfer and recurrence. ACCB Biotech's product lineup features various diagnostic tools, such as EnzymAct and Gene 21 of Breast Cancer, along with automated workstations for nucleic acid extraction. The company operates facilities exceeding 3,000 square meters, meeting stringent cleanliness standards. Established in June 2009, ACCB Biotech's EnzymAct® received approval from the State Food and Drug Administration, marking a significant milestone in its commitment to developing advanced molecular diagnostic products for precision medicine and individualized treatment plans.
Yitongwen
Private Equity Round in 2017
Yitongwen provides an overall preschool education solutions that focusing on content innovation. It is a cultural and creative enterprise integrating educational technology innovation, product design innovation, network training innovation, and educational service innovation. , educational books, educational equipment, teacher training, network services and other high-quality products. Among them are educational equipment products that include five series of learning materials, game materials, sports materials, living materials, and home education.
Inno Laser
Venture Round in 2016
Inno Laser Technology Co Ltd is engaged in the research, development, production, and sales of advanced laser systems, specializing in micromachining applications. The company produces a range of lasers, including nanosecond, sub-nanosecond, picosecond, and femtosecond lasers, which are utilized for precise microfabrication processes. Inno Laser also offers customized laser modules to meet the specific needs of its customers, enhancing their capabilities in various industrial and technological applications.
Beijing ACCB Biotech
Venture Round in 2016
Beijing ACCB Biotech Ltd. specializes in the research and development of cancer detection methods utilizing molecular biology technologies. The company offers a range of services centered on personalized therapy, including early cancer screening, drug selection, effect tracking, prognostic evaluation, and monitoring for transfer and recurrence. ACCB Biotech's product lineup features various diagnostic tools, such as EnzymAct and Gene 21 of Breast Cancer, along with automated workstations for nucleic acid extraction. The company operates facilities exceeding 3,000 square meters, meeting stringent cleanliness standards. Established in June 2009, ACCB Biotech's EnzymAct® received approval from the State Food and Drug Administration, marking a significant milestone in its commitment to developing advanced molecular diagnostic products for precision medicine and individualized treatment plans.
Kuai CTO
Angel Round in 2016
Kuai CTO provides big data, cloud computing, smart hardware and artificial intelligence services.
Moatable
Post in 2016
Renren Inc. operates primarily as a used automobile retailer in the People's Republic of China, offering a range of vehicles from brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company facilitates financing options for customers through partnerships with financial services and provides credit financing to used car dealers. Additionally, Renren offers value-added services, including warranties, insurance, and after-sale support. The company leverages its online platforms, including the Kaixin Auto app and other vertical channels, to reach customers. Beyond the automotive sector, Renren also develops the Chime platform, which provides lead generation and customer relationship management solutions tailored for real estate professionals in the United States. Furthermore, it offers online and mobile services for the trucking industry. Originally founded in 2002 as Oak Pacific Interactive, the company rebranded to Renren Inc. in 2010, and is headquartered in Beijing.
Renren Games
Series A in 2016
Renren Games offers gaming and entertainment services.
Bay Environmental Technology (Bayeco)
Venture Round in 2016
Bay Environmental Technology (Beijing) Corp, commonly known as Bayeco, specializes in environmental protection solutions tailored for the petrochemical and industrial sectors. The company focuses on air pollution control, offering services such as volatile organic compound (VOCs) treatment, vapor recovery systems, and PM2.5 treatment. Its applications are designed to address the needs of refinery plants, gas stations, oil depots, and process boilers. Bayeco has distinguished itself in the industry by being recognized as the first state environmental protection engineering center for VOC control in petrochemical industries. Through its comprehensive services, Bayeco aims to assist clients in effectively managing and reducing environmental pollutants, thereby promoting cleaner industrial operations.
Mingde Bio
Private Equity Round in 2016
Mingde Bio is a high-tech biotechnology company that specializes in the R&D, production, and sales of rapid diagnostic reagents. The company has more than 30 POCT rapid diagnostic reagent products and has become one of the most comprehensive domestic companies with product lines. In July 2018, it was officially listed on the Small and Medium-sized Board of the Shenzhen Stock Exchange with the stock code 002932.
Waluer
Private Equity Round in 2016
Waluer is an integrated service provider in the field of mobile culture and entertainment industry. Its main business is to provide content integrated distribution, channel marketing promotion and product payment calculation for mobile entertainment products.
Junmeng Game Online Game Industry
Private Equity Round in 2016
Junmeng Game Online Game Industry is engaged in the development and operation of web games and social games. Established in 2009, Junmeng is composed by a large number of elite talents and venture capital of domestic first-tier online game companies.
Tiansheng Pharmaceutical Group
Private Equity Round in 2016
Tiansheng Pharmaceutical Group is a Chinese pharmaceutical company engaged in the research, development, production, and sales of a wide range of pharmaceutical products. The company specializes in manufacturing various medicines, including baikejing granules and pediatric lung cough granules, addressing diverse therapeutic areas such as respiratory, digestive, cardiovascular, oncology, and gynecological health. Tiansheng also involves itself in the circulation of pharmaceuticals and the planting and processing of Chinese herbal medicine. Their products are accessible for online shopping, and customer inquiries are managed through multiple channels, including phone, email, and online applications.
Kawin Technology
Venture Round in 2016
Beijing Kawin Technology Share-Holding Co., Ltd. is a biotechnology company based in the Beijing Economy-Technology Development Area, known as the "Pharmaceutical Valley." The company specializes in developing healthcare solutions for liver diseases, offering products such as Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound Glycyrrhizin Capsules. Since its establishment, Kawin Technology has formed strategic partnerships with notable firms, including Legend Capital, Haitong Capital, and Cybernaut. Recognized as a High & New Technology Enterprise by the Beijing Municipal Science & Technology Commission, the company has also been listed among the Hundred Pilot Enterprises and the Top 100 Most-Promising Enterprises by Zhongguancun Technology Park, often referred to as China’s Silicon Valley.
Biomarker Technologies
Private Equity Round in 2016
Biomarker Technologies, established in 2009 and based in Beijing, China, specializes in comprehensive genomic services that integrate scientific research with medical technology. The company offers a range of services, including gene sequencing, medical testing, and biological research, aimed at enhancing research capabilities for clients across various sectors. With a dedicated research and development team exceeding 500 members, Biomarker Technologies comprises highly educated professionals, including bioinformaticians, senior engineers, and experts from biotechnology, agriculture, medicine, and computing fields. This diverse expertise positions the company as a significant player in the genetic industry, committed to advancing scientific knowledge and medical applications.
H&R Century
Post in 2016
H&R Century (欢瑞世纪) is a company focused on the investment, production, and publication of TV series and the development of relevant industries. It is focused on the market of young audience, and takes youth, vigor, and fashion as standards to create works that represent the tastes and aesthetic interests of young people. H&R Century has produced works such as "Heart Lock Jade Palace", "Palace Ⅱ", "The Cost of The Bachelorettes”, “Midsummer Clear Day", "Times of The Bachelorettes, Painted Skin Ⅱ", and more. It has also invested in filming several films such as "Painted Skin Ⅱ", "Tiny Times", “Tiny Times Ⅱ”, and “Aoki Era". Founded in 2006, H&R Century has 14 male artists and 12 female artists, and has signed with 7 Star Studios including Yang Mi, Liu Kaiwei, Tang Yan, Jia Nailiang, and more.
Shenzhen New Industries Biomedical Engineering
Private Equity Round in 2016
Shenzhen New Industries Biomedical Engineering Co., Ltd. is a biomedical company based in Shenzhen, China, established in 1995. It focuses on the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents for hospitals and laboratories both domestically and internationally. The company offers a range of products, including immunology and clinical chemistry systems, as well as immunoassay and clinical chemistry reagent kits. Its operations encompass dedicated centers for research and development, production of reagents and instruments, and sales and marketing activities, enabling it to effectively serve the healthcare sector.
HUNAN TEA GROUP CO.,LTD
Private Equity Round in 2016
Hunan Tea Industry is a supplier of tea products. They provide products that include tea planting, processing, scientific research, sales, and tea. An online inquiry form is available on the company's website.
Tiansheng Pharmaceutical
Private Equity Round in 2016
Tiansheng Pharmaceutical is a manufacturer of gelatin products and Chinese patent medicines.
Biomarker Technologies
Series B in 2015
Biomarker Technologies, established in 2009 and based in Beijing, China, specializes in comprehensive genomic services that integrate scientific research with medical technology. The company offers a range of services, including gene sequencing, medical testing, and biological research, aimed at enhancing research capabilities for clients across various sectors. With a dedicated research and development team exceeding 500 members, Biomarker Technologies comprises highly educated professionals, including bioinformaticians, senior engineers, and experts from biotechnology, agriculture, medicine, and computing fields. This diverse expertise positions the company as a significant player in the genetic industry, committed to advancing scientific knowledge and medical applications.
Shanghai Medicilon
Series B in 2015
Shanghai Medicilon Inc. is a contract research organization (CRO) based in Shanghai, China, that specializes in drug discovery and development services for pharmaceutical and biotechnology companies both domestically and internationally. Established in 2004, the company offers a wide array of services, including medicinal chemistry, analytical chemistry, drug formulation, and preclinical research. Its biology services encompass recombinant protein production, structural biology, discovery biology, and computational modeling, while pharmacology services cover various disease models and bioanalytical services. Medicilon also provides preclinical pharmacokinetic and safety evaluations, ensuring compliance with international standards. With its integrated technical platform, the company aims to meet the innovative demands of the global pharmaceutical industry and supports the development of new drugs through comprehensive R&D services.
HUNAN TEA GROUP CO.,LTD
Series A in 2013
Hunan Tea Industry is a supplier of tea products. They provide products that include tea planting, processing, scientific research, sales, and tea. An online inquiry form is available on the company's website.
Shanghai Medicilon
Series B in 2013
Shanghai Medicilon Inc. is a contract research organization (CRO) based in Shanghai, China, that specializes in drug discovery and development services for pharmaceutical and biotechnology companies both domestically and internationally. Established in 2004, the company offers a wide array of services, including medicinal chemistry, analytical chemistry, drug formulation, and preclinical research. Its biology services encompass recombinant protein production, structural biology, discovery biology, and computational modeling, while pharmacology services cover various disease models and bioanalytical services. Medicilon also provides preclinical pharmacokinetic and safety evaluations, ensuring compliance with international standards. With its integrated technical platform, the company aims to meet the innovative demands of the global pharmaceutical industry and supports the development of new drugs through comprehensive R&D services.
Dream
Series B in 2012
Dream is a company that offers game creation services with the goal of creating a variety of web games, social games, and mobile Internet games. Clients can access a variety of online games cause of the company's gaming development services, which include numerous cross-platform gaming facilities that are also exported to other markets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.